- Release Date: 11/01/21 09:34
- Summary: European Commission grants 3 NNZ-2591 Orphan designations
- Price Sensitive: Yes
- Download Document 143.44KB
- Forums
- ASX - By Stock
- NEU
- Ann: European Commission grants 3 NNZ-2591 Orphan designations
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.32%
!
$17.55

Ann: European Commission grants 3 NNZ-2591 Orphan designations
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.55 |
Change
-0.235(1.32%) |
Mkt cap ! $2.211B |
Open | High | Low | Value | Volume |
$17.67 | $18.02 | $17.52 | $6.970M | 393.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 785 | $17.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.55 | 2372 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 184 | 17.530 |
12 | 1216 | 17.520 |
15 | 2003 | 17.510 |
14 | 8864 | 17.500 |
12 | 1837 | 17.490 |
Price($) | Vol. | No. |
---|---|---|
17.540 | 2181 | 15 |
17.550 | 2137 | 15 |
17.560 | 3129 | 25 |
17.570 | 2013 | 18 |
17.580 | 1449 | 7 |
Last trade - 15.47pm 11/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online